Printer Friendly

Herbal melanin modulates tumor necrosis factor alpha (TNF-[alpha]), interleukin 6 (IL-6) and vascular endothelial growth factor (VEGF) production.


Recent studies have indicated that cytokines can enhance immunogenicity and promote tumor regression. However, the means for modulating cytokine production are not yet fully investigated. In this study we report the effects of a herbal melanin, extracted from Nigella sativa L., on the production of three cytokines [tumor necrosis factor alpha (TNF-[alpha]), interleukin 6 (IL-6) and vascular endothelial growth factor (VEGF)], by human monocytes, total peripheral blood mononuclear cells (PBMC) and THP-1 cell line. Cells were treated with variable concentrations of melanin and the expression of TNF-[alpha], IL-6 and VEGF mRNA in cell lysates and secretion of proteins in the supernatants were detected by RT-PCR and ELISA. Melanin induced TNF-[alpha], IL-6 and VEGF mRNA expression by the monocytes, PBMC and THP-1 cell line. On the protein level, melanin significantly induced TNF-[alpha] and IL-6 protein production and inhibited VEGF production by monocytes and PBMC. In the THP-1 cell line melanin induced production of all three cytokine proteins. These observations raise the prospects of using N. sativa L. melanin for treatment of diseases associated with imbalanced cytokine production and for enhancing cancer and other immunotherapies.

[c] 2005 Elsevier GmbH. All rights reserved.

Keywords: Nigella sativa; Melanin; Cytokines; Immunomodulation


Nigella sativa L. (family: Ranunculaceae) is a herbaceous plant growing in the Mediterranean countries and Western Asia. The plant has been considered for millennia as one of the greatest healing herbs and has long been used for strengthening the immune system and for protection against various diseases (Khan, 1999). Voluminous research has been carried out on the medicinal properties of the seeds as antioxidants (Atta and Imaizumi, 1998), antimicrobial (Morsi, 2000), anti-inflammatory (Al-Ghamdi, 2001) and anticancer agents (Awad, 2003; Farah and Begum, 2003; Salomi et al., 1992). Various extractions, previously obtained from N. sativa seeds, included volatile and stable oils, whole and fractionated proteins, carbohydrates, crude fibers and minerals (Khan, 1999). More recently, melanin has been shown to occur abundantly in the seed coats of N. sativa L. (Hassib, 1998). Melanin is a pigment that causes darkness in animal and plant tissues. Although there has been little understanding of melanin morphology, structure and even size, there has been some agreement regarding the molecular units that comprise the polymerized structure. Typical units include dihydroxyindole (DHI), dihydroxyindole-carboxylic acid (DHICA), and 5,6-indolequinone (IQ) (Stark et al., 2003; Tian et al., 2003). Melanins are divided into three groups: allomelanins in the plant kingdom and eumelanins and phaeomelanins in the animal kingdom. All melanins show a large content of stable free radicals, that are easily detectable by electron spin resonance (ESR) and all show pronounced radical scavenging ability and metal chelation properties, both of these properties have been related to their general protective and antioxidant behavior (Pathak, 1995). Most of the plant melanins have not yet been given adequate attention in terms of their potential therapeutic uses. This study has been prompted by recent findings that melanin, from a number of botanical sources, has been found to be an immunologically active modulator of cytokines (Avramidis et al., 1998; Mohagheghpour et al., 2000; Pugh et al., 2005; Pasco et al., 2005). None of these studies have mentioned N. sativa L. as a source of melanin.

Cytokines are relatively low-molecular-weight proteins produced by many cell types (Feghali and Wright, 1997). They are pharmacologically active, exhibiting both beneficial and pathologic effects on the target cells. Imbalanced expression of cytokines has been implicated in the progression of many diseases (Arend and Gabay, 2004). Tumor necrosis factor alpha (TNF-[alpha]) is a major immune response-modifying cytokines produced primarily by cells of monocytic lineage. TNF-[alpha] has been shown to enhance antitumor responses and to promote tumor regression (Peron et al., 1999). Interleukin 6 (IL-6) is a cytokine produced by a number of normal and transformed cells (Bartold and Haynes, 1991; Van Meir et al., 1990). IL-6 promotes or inhibits the growth of tumor cells depending upon the cell type (Lu et al., 1995). Vascular endothelial growth factor (VEGF) is a potent multifunctional angiogenic cytokine (Brown et al., 1997). VEGF overproduction has been implicated in hematologic malignancies (Di Raimondo et al., 2000).

In the present study we report on possible immunogenic activity of a melanin extract from N. sativa, as evidenced by its effects on the expression of the three cytokines: TNF-[alpha], IL-6 and VEGF by monocytes, mixed PBMC cultures and THP-1 cell line THP-1. Our results indicate that melanin extracted from N. sativa significantly modulates the expression of TNF-[alpha], IL-6 and VEGF by the human monocytes, PBMC and THP-1 cell line. This finding suggests that N. sativa melanins may have an immunoregulatory activity that could contribute to future therapeutic interventions relating to diseases associated with imbalanced cytokine production and cancer.

Materials and methods

Preparation and characterization of N. sativa L. herbal melanin

Melanin has been extracted from the seed coats of the well-known herb N. sativa via alkali solublization and acid aggregation; purified by washing in excess amounts of highly distilled water and vacuum drying. The melanin nature of the extract has been verified via the standard analytical techniques: ESR, infra red (IR), ultraviolet-visible (UV-VIS), Nuclear Magnetic Resonance (NMR), XRD, Fluorescence, Solubility studies, amino acid composition and elemental analysis. The elemental analysis of carbon, hydrogen and nitrogen gave the (wt/wt percent) ratios of: 50.29, 5.77 and 4.4, respectively. The amino acid composition of the extract is as given in Table 1. These results are similar to the relative amino acid compositions, obtained for other melanins, published by Lisa Zeise (Zeise, 1995). The characterization of the extracted N. sativa melanin, using UV-VIS spectra for various concentrations, is as shown in Fig. 1a. The spectra show the well-known monotonically increasing absorption of melanin for photons of decreasing wavelength. The IR spectrum of NS melanin powder (1% in K Br pellets) (data not shown) agrees very well with the results reported in earlier studies of melanins from other sources (Bilinska, 1996). These spectra are characterized by strong absorption near the wave numbers of 1200, 1660, 2800-3100, 3400[cm.sup.-1]. All melanin are rich in natural stable free radicals that are easily detectable by ESR. ESR of the NS melanin, using an x-band spectrometer, has shown a single symmetrical line of narrow width (7-8G) at a g-value of 2.004 without a resolvable hyperfine interaction, as shown in Fig. 1b. The spin concentration for this resonance has been calculated to be around [10.sup.17] spins per gram at room temperature. The number of spins showed a little variation with variation in the extraction method. However, the line intensity increased, in accordance with the source intensity, on exposure of the NS melanin to UV (250 nm) radiations in situ. Both of the XRD and the NMR has shown very dense, overlapping broad spectral lines that are not amenable to detailed analysis. This is typical of melanins because of the interference of the free radicals with the NMR spectrum and the broad diffractions by the highly heterogeneous amorphous melanins in XRD.


The dark black to brown powders which we extracted from N. sativa (and would refer to, henceforth as herbal melanin (HM)), satisfy, in accordance with the above-mentioned studies, the standard criteria for melanin pigments as suggested by Zeise (Zeise, 1995).

The HM dried powders were dissolved in 0.1 M NaOH solution at a concentration of 1 g/l. The pH of the melanin solution was subsequently adjusted to pH 7.0, using concentrated HCl and filtered through 0.4 [micro]m filters. Melanin stock solutions for experimental use were prepared in distilled water at concentrations of 0.1-1 g/l.

Cell culture conditions

Human monocytic THP-1 cells were obtained from American Type Culture Collection (ATCC, Rockville, MD, USA). The cells were maintained in RPMI 1640 (ATCC, Rockville, MD, USA), supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin (Gibco BRL) in a humidified atmosphere of air with C[O.sub.2] 5% at 37[degrees]C. The medium was replaced 24 h prior to experiments by serum-free RPMI 1640 medium to avoid the effects of serum on gene expression.

Blood cells isolation

In order to isolate human peripheral blood mononuclear cells (PBMC), blood was collected from healthy human volunteers (age ranging 22-45). Informed consent was obtained before a 30 ml volume of peripheral blood was collected by venipuncture in sterilized ethylenediamine tetra-acetic acid (EDTA) tubes. PBMCs were separated on Ficoll-Paque density gradients (Pharmacia Biotech, Uppsala, Sweden) and cells from the interface were washed twice with calcium and magnesium free phosphate buffer saline (PBS) and seeded at a density of 1 x [10.sup.6] cells/ml per well in 24-well microtiter plates in RPMI-1640 medium. For isolation of monocytes, PBMC were plated for 2 h and the non-adherent cells were removed with three changes of warm PBS. Pure monocytes were then positively selected by means of anti-CD 14-coated microbeads (MiniMACS separation column; Milteny Biotec, Auburn, CA) following manufacturer's instructions. Flow cytometry analysis, using CD-14 and CD-45 antigen expression, showed that more than 90% of the cells were monocytes.

Induction and analysis of cytokine mRNA levels

Monocytes and PBMC (1 x [10.sup.6] cells/ml) were treated with HM melanin solutions at concentrations of 50 and 100 [micro]g/ml. The expression of TNF-[alpha], IL-6 and VEGF mRNA was tested 3 h later. THP-1 cells were similarly treated with HM and mRNA expression was tested after 3 h for TNF-[alpha] and after 24 h for IL-6 and VEGF. Escherichia coli lipopolysaccharide (LPS) was used as a positive control stimulus for cytokines induction at a concentration of 10 [micro]g/ml (E. coli LPS 026:B5 Sigma). Control cells from monocytes and PBMC taken from the same subject and control THP-1 cells were used as controls.

Total cellular RNA was extracted from monocytes, PBMC and THP-1 cells using TRIzol reagent (Invitrogen) according to manufacturer's instructions. Two micrograms of total RNA were reverse transcribed into single stranded cDNA in a reaction mixture (30 [micro]l) containing 1 x reaction buffer (50 mM Tris-HCl pH 8.3, 75 mM KCl and 3 mM Mg[Cl.sub.2]), 0.5 mM deoxynucleoside triphosphate mixture, 1 U of RNasin per [micro]l, 1.5 mM. oligo(dT) primer, and 10 U of Moloney murine leukemia virus reverse transcriptase (Clontech Laboratories, Inc., Palo Alto, Calif.) per [micro]l at 42[degrees]C for 1 h. Reverse transcription was inactivated at 95[degrees]C for 5 min and the products were kept on ice until needed for the PCR.

Amplification of cytokine cDNA was carried out using PCR primers obtained from Aragene Company (Aragene, Riyadh, Saudi Arabia). The primers used for TNF-[alpha] sense and antisense, respectively, were CTT-CTG-CCT-GCT-GCA-CTT-TGG-A and TCC-CAA-AGT-AGA-CCT-GCC-CAG-A. Conditions for RT-PCR were 30 cycles of 94[degrees]C for 30 s, 62[degrees]C for 1 min, 72[degrees]C for 2 min. Primers used for IL-6 were ATG-AAC-TCC-TTC-TCC-ACA-AGC-GC and GAA-GAG-CCC-TCA-GGC-TGG-ACT-G. Conditions for RT-PCR were 30 cycles of 94[degrees]C for 30 s, 65[degrees]C for 2 min, and 72[degrees]C for 2 min. The primers and RT-PCR conditions used for VEGF and VEGF isoforms (VEGF 121, VEGF165 and VEGF189) were described previously (El-Obeid et al., 2004). The house keeping gene, [beta]-actin, was used as an internal control for RT-PCR assay. The primers used for [beta]-actin were ATC-TGG-CAC-CAC-ACC-TTC-TAC-AAT-GAG-CTG-CG and CGT-CAT-ACT-CCT-GCT-TGC-TGA-TCC-ACA-TCT-GC. Conditions for RT-PCR were 40 cycles of 94[degrees]C for 45 s, 61[degrees]C for 45 s and 72[degrees]C for 2 min. The products were separated on a 2% agarose gel using electrophoresis and visualized by ethidium bromide staining.

Induction and analysis of cytokine protein levels

Protein secretion was tested in order to find out whether the changes in the cytokine mRNA levels following HM treatment were paralleled by changes in the cytokines produced. Cells from monocytes, PBMC and THP-1 were seeded at 1 x [10.sup.6] cells/ml in 12-well dishes. Cells were treated with HM (10, 50 and 100 [micro]g/ml) or LPS (10 mg/ml) for 24 h before collecting the supernatants. The levels of cytokine proteins produced in the supernatant were assayed by ELISA (R & D Sys., Minneapolis, MN, USA) following manufacturer's instruction. Supernatants were used as collected or at diluted concentrations. RPMI-1640 media were used as negative controls. Additional control was obtained by incubating 100 [micro]g HM in RPMI-1640 media for 24 h at 37[degrees]C. Duplicate readings for each standard, control and sample were recorded. The average absorbance for each duplicate set of standards, controls, and samples was calculated using a standard curve. Concentrations were determined by extrapolation on the standard curve. It was verified that the addition of different concentrations of HM, in supernatants collected from HM treated cells, did not interfere with the measurements by determining the concentrations of the cytokines from control standard curves. These were constructed by plotting optical density values obtained from cytokine standards diluted in medium incubated with 100 [micro]g/ml HM for 24 h at 37[degrees]C. Repeated assays showed that HM did not affect the outcome of the cytokine assay (data not shown).

Cellular toxicity assay

The toxicity of HM on THP-1 was determined by the 3-(4,5dimethylthiazoly1-2)-2, 5-diphenyltetrazolium bromide (MTT) cell proliferation assay according to manufacturer's instruction (MTT# 30-101K. ATCC Rockville, MD, USA). Briefly, THP-1 cells were plated in triplicate at [10.sup.3] cells/ml and, subsequent to 6 h incubation at 37[degrees]C in 5% C[O.sub.2] incubator, HM was added at the concentration of 10, 50 and 100 [micro]g/ml. The medium was also used as a control to provide the blank for absorbance readings. Four hours before the 24-h time point, 10 ml of the MTT Reagent were added for 2 h followed by 100 ml of the Detergent Reagent. After 2 h incubation in the dark, the plates were read for absorption at 570 nm ([A.sub.570]) in an automatic ELISA plate reader. The results were quantified as optical density (O.D.) at 570 nm of cultures exposed to HM or non-exposed media.

Statistical analysis

All values were expressed as means [+ or -] standard error. Statistical differences were estimated by Mann-Whitney Test. Values of p<0.05 were considered significant.


Cytokine mRNA expression in human monocytes, PBMC and THP-1

RT-PCR showed low expression of 517 bp TNF-[alpha] transcript (Fig. 2, lane a) and 627 bp IL-6 transcript (Fig. 2, lane b) for control monocytes, which became more pronounced on addition of LPS (10 [micro]g/ml). Treatment with HM at 50 and 100 [micro]g/ml clearly induced both TNF-[alpha] and IL-6 mRNA expression as compared with control cells. Similarly, control PBMC showed low expression of TNF-[alpha] and IL-6 mRNA (Fig. 3, lanes a, b). Addition of HM and LPS up-regulated the expression of both cytokines.

Both control and LPS-treated monocytes (Fig. 2, lanes c, d) and PBMC (Fig. 3, lanes c, d) expressed the 334-bp band of the VEGF transcripts and VEGF isoforms VEGF121(435 bp) and VEGF165 (567 bp) transcripts, coding for the smallest secretable VEGF isoforms (Robinson and Stringer, 2001), while the larger cytoplasmic associated variant VEGF 189 (639 bp) was not expressed. Addition of HM at 50 [micro]g/ml slightly induced mRNA expression of the detected VEGF isoforms in monocytes (Fig. 2, lanes c, d) and PBMC (Fig. 3, lanes c, d). The house keeping gene, [beta]-actin, indicated comparable levels of the internal mRNA in the control and treated monocytes (Fig. 2, lane e) and PBMC (Fig. 3, lane e).



Control THP-1 cells expressed low levels of TNF-[alpha], IL-6, VEGF and VEGF 121, 165, 189 isoforms mRNA but not IL-6 mRNA. Addition of LPS and HM slightly induced the expression of the three cytokines (data not shown).

Cytokines secretion in human monocytes and PBMC

As shown in Fig. 4a control monocytes produced low levels of TNF-[alpha] protein. Addition of LPS (10 [micro]g/ml) strongly induced the production of TNF-[alpha] protein, as was previously reported (Bruggen et al., 1999). Our results clearly demonstrate that HM at 10, 50 and 100 [micro]g/ml induced TNF-[alpha] production in a dose-dependent manner. Similarly, control monocytes, that expressed low levels of IL-6, produced high levels of IL-6 on treatment with LPS or HM (Fig. 4b). Significant increase in TNF-[alpha] and IL-6 production was shown on using HM at concentration of 100 [micro]g/ml (p = 0.014 and p = 0.025, respectively). Both TNF-[alpha] and IL-6 results for protein expression agreed with our RT-PCR results.

Control monocytes constitutively secreted a mean of 67.81 pg/ml of VEGF (Fig. 4c). LPS induced the expression of VEGF to 89.14 pg/ml. In contrast to TNF-[alpha] and IL-6 results, the addition of HM inhibited the production of VEGF protein to very low or to undetectable levels giving a mean of 22.9 pg/ml (0.00-45.81 pg/ml). However, no inhibitory effect of HM on VEGF transcripts was detected by our RT-PCR.

PBMC spontaneously secreted a mean of 396.07 pg/ml (20.00-772.15 pg/ml) of TNF-[alpha] and 253.15 pg/ml (200.00-306.30) of IL-6 that were induced by LPS treatment (data not shown). On treating the cells with HM at 10, 50 and 100 [micro]g/ml the basal secretions of both of TNF-[alpha] and IL-6 were strongly induced to levels that could not be read by the machine. The supernatants had to be diluted down to 1:100 for TNF-[alpha] and 1:200 for IL-6 in order to carry out the assay. At the concentration of 100 [micro]g/ml, HM increased TNF-[alpha] production to about 45-fold over that of the control and increased IL-6 production to about 318-fold over that of the controls.

Detectable levels of VEGF have been secreted by the control and LPS-treated PBMC. Treatment with HM suppressed VEGF production by PBMC from 83.49 pg/ml (51.95-115.02 pg/ml) that secreted by control cells to 20.50 pg/ml (3.88-37.12 pg/ml) secreted by HM-treated cells.


Cytokines secretion in THP-1 cells

A very low level of TNF-[alpha] has been detected in the culture supernatant of control THP-1 having a mean of 21.35 pg/ml (Fig. 5a). This result is supported by our RT-PCR results, indicating that THP-1 cells have constitutively produced low levels of TNF-[alpha]. Treatment of the cells with LPS significantly increased TNF-[alpha] production (p = 0.020). Addition of HM at 50 and 100 [micro]g/ml increased TNF-[alpha] production to 276.80 and 249.42 pg/ml, respectively.

Fig. 5b shows no expression of IL-6 protein by control THP-1 cells. LPS significantly induced IL-production (p = 0.037). HM at 50 and 100 [micro]g/ml induced IL-6 production to 16.85 and 7.42 pg/ml, respectively.

As shown by Fig. 5c, control THP-1 cells constitutively secreted a mean of 346.40 pg/ml of VEGF protein that have been induced by LPS treatment to 911.70 pg/ml and by HM (50 and 100 [micro]g/ml) to 912.37 and 769.97 pg/ml, respectively.

Results of cellular toxicity assay

In order to check if the concentrations of HM used in the study caused cell toxicity or affected the viability of the cells we performed MTT cell proliferation assay. THP-1 cells were cultured in the presence and absence of 10, 50 and 100 [micro]g/ml of HM. Fig. 6 showed that HM is not toxic to the cells even at the highest employed concentrations (p = 0.166) as determined by four separate experiments.


In this study, we tested the effect of melanin extracted from N. sativa L. on the production of TNF-[alpha], IL-6 and VEGF in human monocytes, PBMC and THP-1 cell line on the transcriptional and translational levels. Melanin significantly induced the production of TNF-[alpha] and IL-6 and inhibited the production of VEGF by monocytes and PBMC. Treatment of THP-1 cell line with melanin induced the production of TNF-[alpha], IL-6 and VEGF.


Previous studies on the effects of N. sativa on the immune system have shown that total extracts of N. sativa or its fractionated proteins could modulate cytokines production (Haq et al., 1999; Swamy and Tan, 2000). However, in these studies the actual effective component(s) in N. sativa underlying the results obtained remained to be identified. On the other hand, recent studies have shown that both synthetic melanin (Mohagheghpour et al., 2000) and plant melanin (Avramidis et al., 1998) can also modulate cytokines production.

Our data are, however, the first to specify that melanin extracted from N. sativa has a direct modulatory effect on cytokine production by monocytes, PBMC and THP-1 cells. RT-PCR results showed that HM up-regulated the expression of TNF-[alpha] and IL-6 mRNA in monocytes and PBMC in a dose-dependent manner. These findings were corroborated through ELISA determination of TNF-[alpha] and IL-6 protein expression under the same experimental conditions. The levels of both cytokines were significantly elevated following treatment with HM. VEGF expression was also found to change after melanin treatment. In contrast to its action on TNF-[alpha] and IL-6, HM inhibited the secretion of basal VEGF by monocytes and BPMC.

Because of potential variability in cytokine production by monocytes and PBMC from different individuals (Jacob et al., 1990; Webb and Chaplin, 1990), we used the human monocytic cell line, THP-1, that exhibits high inducibility for TNF-[alpha] gene transcription similar to that of freshly isolated monocytes (Yao et al., 1997). HM induced mRNA expression and increased the spontaneous production of TNF-[alpha], IL-6 and VEGF by the THP-1 cells, thus providing further evidence of its modulatory effect on cytokines. Recently, Pasco and coworkers (Pugh et al., 2005) tested the effect of Echinacea melanin on THP-1 cells and reported that it increased the production of IL-1[beta] in a dose-dependent manner. They also showed that melanin has a direct effect on mice mucosal immune function that results in an increased production ex vivo of interferon-[gamma], IgA and IL-6.


The genes of TNF-[alpha], IL-6 and VEGF in human monocytes and PBMC are generally under strict inductional control. Nonetheless, a variety of stimuli, such as endotoxins and other cytokines, are known to modulate their expression (Bruggen et al., 1999; Sakuta et al., 2001; Tosato and Jones, 1990). The exact mechanism(s) by which melanin molecules affect genes transcription and cytokines production are not yet determined, though their roles as antioxidants, free radical scavengers plus their possession of a rich content of stable free radicals are well documented (Bustamante et al., 1993; Enochs et al., 1993; Zeise, 1995; Pathak, 1995; Riley, 1997; Sichel et al., 1991). Melanin molecules regulate gene expression of several cytokines by modulating the genes and transcription factors that are involved in the immune responses (Marui et al., 1993; Weber et al., 1994; Munoz et al., 1996). Nathens et al. (2001) have shown that antioxidant pyrrolidine dithiocarbamate increases LPS-stimulated TNF-[alpha] release in murine macrophages. They suggested stimulatory and species-dependent role of antioxidant on gene expression (Nathens et al., 2001). The increased secretion of TNF-[alpha] and IL-6 by monocytes, PBMC and THP-1 cells, after HM treatment, might suggest a similar possibility of a modulatory effect of melanin as an antioxidant and free radical scavenger on cytokines expression.

The use of cytokines and cytokine genes such as TNF-[alpha] and IL-6 to promote tumor regression/rejection has been established in various mouse tumor models (Colombo et al., 1992; Fearon et al., 1990). Recently, Xiao et al. have shown that IL-6 could inhibit the growth and development of colon cancer (Xiao et al., 2000). Thus, HM might be applied, within novel approaches, for boosting of anticancer immunotherapy.

VEGF is an important angiogenic cytokine with critical roles in tumor angiogenesis (Dvorak, 2002). Different strategies have been developed to inhibit VEGF and the kinase activity of VEGFR (Melnyk et al., 1999; Chen et al., 1997; Ogawa et al., 2002). Our results indicate that HM significantly inhibits VEGF production by monocytes and PBMC. This result might have a profound effect on therapeutic strategies aimed at inhibiting VEGF overproduction and related diseases (Bell et al., 1999; Dvorak, 2002; Kim et al., 1993).

Modulation of cytokines production by a herbal extract from a well-known herbal spice is interesting in view of its safety as a harmless non-toxic natural product in common use. The results presented here should also merit further detailed studies of correlation of the properties of melanin with the well-known folk medicinal attributes of N. sativa L.


We are thankful to Prof. M.H. Faris for reading and commenting on the manuscript, Dr. Gamal Mohamed for assistance with the statistical analysis and Mr. Ibrahim Awad Mohammed for preparation of the drawings.


Al-Ghamdi, M.S., 2001. Ant-inflammatory, analgesic and anti-pyretic activity of Nigella sativa. J. Ethnopharmacol. 76, 45-48.

Arend, W.P., Gabay, C., 2004. Cytokines in the rheumatic diseases. Rev. Rheum. Dis. Clin. North Am. 30, 41-67.

Atta, M.B., Imaizumi, k., 1998. Natural antioxidant occurring in Nigella (Nigella sativa L.) seeds. Jpn. Oil Chem. Soc. 47, 475-480.

Avramidis, N., Kourounakis, A., Hadjipetrou, L., Senchuk, V., 1998. Anti-inflammatory and immunomodulating properties of grape melanin. Inhibitory effects on paw edema and adjuvant induced disease. Arzneimittelforschung 48, 764-771.

Awad, E.M., 2003. In vitro decreases of the fibrinolytic potential of cultured human fibrosarcoma cell line, HT1080, by Nigella sativa oil. Phytomedicine 12, 100-107.

Bartold, P.M., Haynes, D.R., 1991. Interleukin-6 production by human gingival fibroblasts. J. Periodontal Res. 26, 339-345.

Bell, C., Lyman, E., Langfair, D.J., Bell, C., Janjic, N., Wiles, M.E., 1999. Oligonucleotide NX 1838 inhibits VEGF 165-mediated cellular responses in vitro. In Vitro Cell Dev. Biol. Anim. 34, 533-542.

Bilinska, B., 1996. Progress on infra red investigations of melanin structures. Spectrochim. Acta A 52, 1157-1162.

Brown, L.F., Detmar, M., Claffey, K., Nagy, J.A., Fenf, D., Dvorak, A.M., Dvorak, H.F., 1997. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. Rev. Exp. 79, 233-269.

Bruggen, T., Nijenhuis, S., Raaij, E., Verhoef, J., Asbeck, B.S., 1999. Lipopolysaccharide-induced tumor necrosis factor alpha production by human monocytes involves the Raf-1/MEK1-MEK2/ERK1-ERK2 pathway. Infect. Immun. 67, 3824-3829.

Bustamante, J., Bredeston, L., Malanga, G., Mordoh, J., 1993. Role of melanin as a scavenger of active oxygen species. Pigment Cell Res. 6, 348-353.

Chen, Z., Fisher, R.J., Riggs, C.W., Rhim, J.S., Lautenberger, J.A., 1997. Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS1 antisense oligonucleotides. Cancer Res. 57, 2013-2019.

Colombo, M.P., Modesti, A., Parmiani, G., Forni, G., 1992. Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk. Rev. Cancer Res. 15, 4853-4857.

Di Raimondo, F., Azzaro, M.P., Palumbo, G., et al., 2000. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood. Haematologica 85, 800-805.

Dvorak, H.F., 2002. Vascular permeability factor/vascular endothelial growth factor a critical cytokine in tumor angiogenesis and potential target for diagnosis and therapy. J. Clin. Oncol. 20, 4368-4380.

El-Obeid, A., Sunnuqrut, N., Hussain, A., et al., 2004. Immature B cell malignancies synthesize VEGF, VEGFR-1 (Flt-1) and VEGFR-2 (KDR). Leuk. Res. 28, 133-137.

Enochs, W.S., Nilges, M.J., Swartz, H.M., 1993. A standardized test for the identification and characterization of melanins using electron paramagnetic resonance (EPR) spectroscopy. Pigment Cell Res. 6, 91-99.

Farah, I.O., Begum, R.A., 2003. Effect of Nigella sativa (N. sativa L.) and oxidative stress pattern of MCF-7 breast cancer cells. Biomed. Sci. Instrum. 39, 359-363.

Fearon, E.R., Pardoll, D.M., Itaya, T., et al., 1990. Interleukin-2 production by tumor cells bypasses T help-function in the generation of an antitumor response. Cell 60, 397-403.

Feghali, C.A., Wright, T.M., 1997. Cytokines in acute and chronic inflammation. Front. Biosci. 2, 12-26.

Haq, A., Lobo, P.I., Al-Tufail, M., Rama, N.R., Al-Sediary, S.T., 1999. Immunomodulating effect of Nigella sativa protein fractionated by ion exchange chromatography. Int. J. Immunopharmacol. 21, 283-285.

Hassib, A., 1998. Extraction of melanin from Nigella sativa L. Patent No. 451, Khartoum, Sudan.

Jacob, C.O., Fronek, Z., Lewis, G.D., et al., 1990. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor-[alpha]: relevance to generic predisposition to systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 87, 1233-1237.

Khan, A.M., 1999. Chemical composition and medical properties of Nigella sativa Linn. Inflammopharmocolgy 7, 15-35.

Kim, K.J., Li, B., Winer, J., et al., 1993. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362, 841-844.

Lu, X.Y., Wang, Z.C., Yang, G.Z., 1995. The relationships between IL-1, IL-6 and tumor. Guowai Yixue Shengli Bingli Kexue Yu Linchuang. Fence. Vol. 15, pp. 159-163.

Marui, N., Offermann, M.K., Swerlick, R., et al., 1993. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J. Clin. Invest. 92, 1866-1874.

Melnyk, O., Zimmerman, M., Kim, K.J., Shuman, M., 1999. Neutralizing anti-vascular endothelial growth factor antibody inhibits further growth of established prostate cancer and metastases in a pre-clinical model. J. Urol. 161, 960-963.

Mohagheghpour, N., Waleh, N., Garger, S.J., Dousman, L., Grill, L.K., Tuse, D., 2000. Synthetic melanin suppresses production of proinflammatory cytokines. Cell Immunol. 199, 25-36.

Morsi, N.M., 2000. Antimicrobial effect of crude extracts of Nigella sativa on multiple antibiotics-resistance bacteria. Acta Microbiol. Pol. 49, 63-74.

Munoz, C., Pascual-Salcedo, D., Castellanos, M.C., et al., 1996. Pyrrolidine dithiocarbamate inhibits the production of interleukin-6, interleukin-8, and granulocyte-macrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediators: modulation of NF-kappa B and AP-1 transcription factors activity. Blood 88, 3482-3490.

Nathens, A.B., Bitar, R., Marshall, J.C., 2001. Antioxidants increase lipopolysaccharide-stimulated TNF alpha release in murine macrophages: role for altered TNF alpha mRNA stability. Shock 16, 361-367.

Ogawa, T., Takayama, K., Takakura, N., Kitano, S., Ueno, H., 2002. Anti-tumor angiogenesis therapy using soluble receptors: enhanced inhibition of tumor growth when soluble fibroblast growth factor receptor-1 is used with soluble vascular endothelial growth factor receptor. Cancer Gene Ther. 9, 633-640.

Pasco, D., Pugh, N.D., Khan, I., Moraes, R., 2005. Immunostimulatory agents in botanicals. U.S patent application Ser. No. 20050002962, January 6, 2005.

Pathak, M.A., 1995. Functions of melanin and protection by melanin. In: Zeise, L., Chedekel, M., Fitzpatrick, T. (Eds.), Melanin: Its Role in Human Photoprotection. Valdenmar Publishing Company, Overland Park, Kansas, pp. 125-133.

Peron, J.M., Shurin, M.R., Lotze, M.T., 1999. Cytokine gene therapy of cancer. In: Lattime, E.C., Gerson, S.L. (Eds.), Gene Therapy of Cancer. Academic Press, Diego, California, USA, pp. 359-371.

Pugh, N.D., Balachandran, P., Lata, H., Dayan, F.E., Joshi, V., Bedir, E., Makino, T., Moraes, R., Khan, I., Pasco, D.S., 2005. Melanin: dietary mucosal immune modulator from Echinacea and other botanical supplements. Int. Immunopharmacol. 5, 637-647.

Riley, P.A., 1997. Molecules in focus: melanin. Int. J. Biochem. Cell Biol. 29, 1235-1239.

Robinson, C.J., Stringer, S.E., 2001. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J. Cell Sci. 114, 853-865.

Sakuta, T., Matsushita, K., Yamaguchi, N., et al., 2001. Enhanced production of vascular endothelial growth factor by human monocytic cells stimulated with endotoxins through transcription factor SP-1. J. Med. Microbiol. 50, 233-237.

Salomi, N.J., Nair, S.C., Jayawardhanan, K.K., Varghese, C.D., Panikkar, K.R., 1992. Antitumour principles from Nigella sativa seeds. Cancer Lett. 63, 41-46.

Sichel, G., Corsaro, C., Scalia, M., Di Bilio, A.J., Bonomo, R.P., 1991. In vitro scavenger activity of some flavonoids and melanins against O2-(dot). Free Radical Biol. Med. 11, 1-8.

Stark, K.B., Gallas, J.M., Zajac, G.W., Eisner, M., Golab, J.T., 2003. Spectroscopic study and simulation from recent structural models for eumelanin: II. Oligomers. J. Phys. Chem. B 107, 11558-11562.

Swamy, S.M.K., Tan, B.K.H., 2000. Cytotoxic and immunopotentiating effects of ethanolic extract of Nigella sativa L. seeds. J. Ethnopharmacol. 70, 1-7.

Tian, S., Garcia-Rivera, J., Yan, B., Casadevall, A., Stark, R.E., 2003. Unlocking the molecular structure of fungal melanin using 13C biosynthetic labelling and solid-state NMR. Biochemistry 42, 8105-8109.

Tosato, G., Jones, K.D., 1990. Interleukin-1 induces inter-leukin-6 production in peripheral blood monocytes. Blood 75, 1305-1310.

Van Meir, E., Sawamura, Y., Diserens, A.C., Hamou, M.F., de Tribolet, N., 1990. Human glioblastoma cells release interleukin 6 in vivo and in vitro. Cancer Res. 50, 6683-6688.

Webb, G., Chaplin, D.D., 1990. Genetic variability at the human tumor necrosis factor loci. J. Immunol. 145, 1278-1285.

Weber, C., Erl, W., Pietsch, A., et al., 1994. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-kappa B mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arterioscler. Thromb. 14, 1665-1673.

Xiao, B., Jing, B., Zhang, Y.L., Zhou, D.Y., Zhang, W.D., 2000. Tumor growth inhibition effect of hIL-6 on colon cancer cells transfected with the target gene by retroviral vector. World J. Gastroenterol. 6, 89-92.

Yao, J., Mackman, N., Edgington, T.S., Fan, S.T., 1997. Lipopolysaccharide induction of tumor necrosis factor--a promotor in human monocytic cells. J. Biol. Chem. 272, 17795-17801.

Zeise, L., 1995. Analytical methods for characterization and identification of melanins. In: Zeise, L., Chedekel, M., Fitzpatrick, T. (Eds.), Melanin: Its Role in Human Photoprotection. Valdenmar Publishing Company, Overland Park, Kansas, pp. 65-79.

A. El-Obeid (a), S. Al-Harbi (a), N. Al-Jomah (a), A. Hassib (b,*)

(a) Biological Repository Center, Department of Molecular Pathology, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia

(b) Faculty of Science, King Saud University, Riyadh, Saudi Arabia

Received 25 November 2004; accepted 17 March 2005

Abbreviations: TNF-[alpha], tumor necrosis factor alpha; IL-6, interleukin 6; VEGF, vascular endothelial growth factor; PBS, phosphate buffer saline; PBMC, peripheral blood mononuclear cells; MTT, 3-(4, 5 dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide; HM, herbal melanin

*Corresponding author. Tel.: +966 1 4676437; fax: +966 1 4608185.

E-mail address: (A. Hassib).
Table 1. Relative amino acid composition (wt/wt %, SD: 0.032) in Nigella
sativa L. melanin

Amino acid % Ratio wt/wt Amino acid % Ratio wt/wt

Aspartic 4.01 Isoleucine 1.68
Threonine 1.91 Leucine 3.05
Serine 1.85 Tyrosine 1.83
Glutamic acid 7.97 Phenylalanin 1.92
Glycine 2.36 Histidine 1.14
Alanine 2.01 Lysine 1.64
Valine 2.40 Arginine 3.58
Methionine 0.52
COPYRIGHT 2006 Urban & Fischer Verlag
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006 Gale, Cengage Learning. All rights reserved.

 Reader Opinion




Article Details
Printer friendly Cite/link Email Feedback
Author:El-Obeid, A.; Al-Harbi, S.; Al-Jomah, N.; Hassib, A.
Publication:Phytomedicine: International Journal of Phytotherapy & Phytopharmacology
Geographic Code:1USA
Date:May 1, 2006
Previous Article:The effect of Kan Jang extract on the pharmacokinetics and pharmacodynamics of warfarin in rats.
Next Article:Selective inhibition of vascular smooth muscle cell proliferation by coptisine isolated from Coptis rhizoma, one of the crude drugs composing Kampo...

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters